Clinerion accelerates drug development using proprietary technologies for analysis of real-world from our global patient network. Clinerion's Patient Network Explorer matches patients to clinical trials, making it easier for them to access the most innovative clinical studies and accelerate the development of new treatments. With key tools for data-driven protocol optimization, site feasibility testing and patient search and re-identification, Patient Network Explorer radically improves efficiency in patient recruitment for clinical trials. Clinerion RWD solutions support the generation of data for real-world evidence, and market access for precision medicines for rare and orphan diseases. As a result, Clinerion supports patients and physicians in bringing early access to innovative medication; helps hospitals to improve access to leading edge sponsored trials; and enables life sciences companies to gain massive time and cost saving.
Company HQ State:
Company HQ Country:
Main Therapeutic Focus:
Lead Product in Development:
Patient Network Explorer (PNEx)
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):